Edge Esmeralda isn’t a typical medical conference. The pop-up village ran from May 30 through June 27 in Healdsburg, California, bringing together founders, researchers, and families across every life stage to live and work alongside each other for a month, running informal experiments in sleep, longevity protocols, and healthy aging along the way.
Inside that village, Edge City hosted its first dedicated Women’s Health Summit, a three-day gathering the organizers framed around a specific gap.
“The female body is one of the most under-measured areas in health,” bringing founders, clinicians, and researchers into a small room to talk about what the next decade of women’s health actually needs to look like. Myra Ahmad was in that room.
For the physician who founded and runs Mochi Health, the invitation tracked closely with where she has said she wants to take the conversation next.
Ahmad has described longevity, encompassing hormone replacement, peptides, skincare, and healthspan more broadly, as the direction she is steering her platform, alongside expansion into dermatology, reproductive health, and integrated lab testing.
A summit built specifically around what’s missing in women’s health research was a natural room for that argument to land in.
A Village Built Around Healthspan
Edge Esmeralda’s premise is unusual by design: toddlers and centenarians living in the same community. Residents running their own experiments on sleep and aging, health treated as a default condition of the environment rather than an intervention layered on top of it.
That framing suits Ahmad, who has spent her career arguing that healthcare fails patients when it treats a condition in isolation instead of the whole person over time, and a village organized around healthspan as an ongoing, lived practice is close to that argument made physical.
The Women’s Health Summit sharpened that same idea into a specific complaint about the research itself.
Ahmad has been direct about the root cause: “protocols were developed around an average trial population that wasn’t representative of women,” she has said, “that is now being distributed through a system that wasn’t designed for women’s actual lives and health needs.”
A summit convened specifically because the female body remains under-measured is, in effect, a room built around fixing the exact mismatch she has spent years describing.
Why a Women’s Health Summit Needed a Seat for Her
Ahmad’s case for who should be building in this space is notably practical. “The majority of patients in healthcare are women,” she has said, “the majority of the frontline healthcare workers are women, and yet historically, the systems, the protocols, the trials, and the founding teams haven’t reflected that.”
A summit convening founders, clinicians, and researchers specifically to correct that imbalance is the kind of room her argument was written for, and her presence there extends a thesis she has been making in interviews and op-eds into an actual working session with the people building the next generation of women’s health tools.
Her Clinical Case for Healthspan Over Weight Alone
The longevity framing also gave Ahmad room to make an argument she’s been building since her MedCity News op-ed on GLP-1 dosing: that the value of these medications isn’t reducible to a number on a scale.
Beyond weight loss, she has pointed to associations between GLP-1s and reduced inflammation, lower cardiovascular risk, and possible neuroprotective effects, the kind of broader metabolic benefit that a healthspan-focused room, rather than a weight-loss-focused one, is built to take seriously. In a village organized around aging well rather than aging fast, that reframing fits the audience precisely.
The Same Thesis, Applied to a New Room
Ahmad’s original question, where patients fall out of care and how to bring them back, was always an argument about continuity.
One trusted relationship, one connected record, over the full span of a patient’s life rather than reassembled after a crisis.
Healthspan is that same continuity thesis pointed forward instead of backward, toward preventing the gaps rather than only repairing them after a patient falls into one.
Where This Positions Her Next
Most of the healthcare industry is still treating longevity as a wellness trend to bolt onto existing product lines.
Ahmad’s appearance at a working summit built by founders and researchers, rather than a consumer-facing wellness stage, puts her a step ahead of that framing.
She isn’t adopting the longevity conversation as a marketing angle. She’s building the clinical case for it in the same room as the people setting its research agenda.
That’s the position she’s been arguing her way into since the company’s founding question, applied now to the decade of women’s health research that room was convened to shape.